» Articles » PMID: 6199209

Mitogenic and Polyclonal B Cell Activation Activities of Synthetic Lipid A Analogues

Overview
Journal Eur J Immunol
Date 1984 Feb 1
PMID 6199209
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The activation of murine B cells and macrophages by synthetic lipid A analogues, solubilized with triethylamine and complexed with bovine serum albumin, were investigated in vitro. The analogues used are nonphosphorylated, C-1 or C-4' monophosphorylated and C-1,4' diphosphorylated derivatives of beta-1,6-linked D-glucosamine disaccharide possessing both ester- and amide-bound fatty acid substituents. They were divided into 4 groups, A, B, C and D in terms of the fatty acid substitution. Ester- and amine-bound fatty acids of the analogues are both tetradecanoic acids (C14) in group A, C14 and (R)-3-hydroxytetradecanoic acids (C14-OH) in group B, both C14-OH in group C and C14-OH and (R)-3-tetradecanoyloxytetradecanoic acids in group D. Mitogenic activity was exhibited in spleen cells from C3H/HeN mice by the C-1 monophosphorylated analogues in groups A and B, and by the C-4' monophosphorylated analogues in groups B, C and D, but not in cells from C3H/HeJ mice. Nonphosphorylated analogues in groups A, B and C, and C-4' monophosphorylated analogue in group A showed negative mitogenic activity. Only the nonphosphorylated analogue in group D exhibited mitogenic activity in spleen cells from C3H/HeJ mice as well as those from C3H/HeN mice. None of the other analogues exhibited the activity in C3H/HeJ spleen cells. Polyclonal B cell activation activity was exhibited by the C-1 monophosphorylated analogues in groups A and B, and by the C-4' monophosphorylated analogues in groups C and D. Nonphosphorylated analogues in all groups and C-4' monophosphorylated analogues in groups A and B showed negative PBA activity. None of the analogues tested could induce any cytostatic macrophages from thioglycollate-elicited peritoneal macrophages.

Citing Articles

Mitogenic activities of synthetic lipid A analogs and suppression of mitogenicity of lipid A.

Tanamoto K, Galanos C, LUDERITZ O, Kusumoto S, Shiba T Infect Immun. 1984; 44(2):427-33.

PMID: 6715043 PMC: 263536. DOI: 10.1128/iai.44.2.427-433.1984.


Immunopharmacological activities of a synthetic counterpart of a biosynthetic lipid A precursor molecule and of its analogs.

Takada H, Kotani S, Tsujimoto M, Ogawa T, Takahashi I, Harada K Infect Immun. 1985; 48(1):219-27.

PMID: 3980084 PMC: 261938. DOI: 10.1128/iai.48.1.219-227.1985.


Immunopotentiator separated from hot water extract of the seed of Benincasa cerifera Savi (Tohgashi).

Kumazawa Y, Nakatsuru Y, Yamada A, Yadomae T, Nishimura C, Otsuka Y Cancer Immunol Immunother. 1985; 19(2):79-84.

PMID: 3872710 PMC: 11039024. DOI: 10.1007/BF00199713.


Importance of fatty acid substituents of chemically synthesized lipid A-subunit analogs in the expression of immunopharmacological activity.

Kumazawa Y, Nakatsuka M, Takimoto H, Furuya T, Nagumo T, Yamamoto A Infect Immun. 1988; 56(1):149-55.

PMID: 3257202 PMC: 259249. DOI: 10.1128/iai.56.1.149-155.1988.


Inhibition of activated nonresponder C3H/HeJ lymphocytes by lipopolysaccharide endotoxin.

SULTZER B, Castagna R Infect Immun. 1988; 56(12):3040-5.

PMID: 2903122 PMC: 259697. DOI: 10.1128/iai.56.12.3040-3045.1988.